| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| BDMDBaird Medical Investment Holdings Limited | 45.91M | 1.25 | 2.55 | 17.74% | 33.62% | 33% | 0.53 | |
| IVFINVO Fertility, Inc. | 12.29M | 0.81 | -0.03 | 116.25% | -417.01% | -495.09% | 0.78 | |
| AEMDAethlon Medical, Inc. | 2.64M | 2.71 | -0.03 | -0.2% | 0.13 | |||
| HYPDHyperion DeFi, Inc. | 27.38M | 3.35 | -0.06 | 14.14% | -73.86% | -36.05% | ||
| NAOVNanoVibronix, Inc. | 1.59M | 1.46 | -0.11 | 12.05% | -133.04% | -8.41% | 0.19 | |
| ALURAllurion Technologies Inc. | 23.21M | 1.89 | -0.16 | -39.94% | -251.56% | |||
| RBOTVicarious Surgical Inc. | 18.48M | 2.86 | -0.27 | -380.42% | 0.30 | |||
| TELATELA Bio, Inc. | 44.09M | 0.99 | -0.74 | 18.56% | -50.61% | -25.05% | 1.51 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 762.87K | 625.49K | 689.38K | 1.07M | 1.66M | 4.08M | 4.14M | 3.08M | 3.23M | 3.29M |
| Revenue Growth % | -0.29% | -0.18% | 0.1% | 0.55% | 0.55% | 1.46% | 0.01% | -0.25% | 0.05% | 0.02% |
| Cost of Goods Sold | 486.21K | 403.99K | 514.44K | 623.17K | 1.08M | 1.43M | 1.94M | 1.64M | 1.93M | 1.84M |
| COGS % of Revenue | 0.64% | 0.65% | 0.75% | 0.58% | 0.65% | 0.35% | 0.47% | 0.53% | 0.6% | 0.56% |
| Gross Profit | 276.66K | 221.49K | 174.93K | 448.73K | 576.41K | 2.66M | 2.19M | 1.45M | 1.3M | 1.45M |
| Gross Margin % | 0.36% | 0.35% | 0.25% | 0.42% | 0.35% | 0.65% | 0.53% | 0.47% | 0.4% | 0.44% |
| Gross Profit Growth % | -0.27% | -0.2% | -0.21% | 1.57% | 0.28% | 3.61% | -0.17% | -0.34% | -0.1% | 0.12% |
| Operating Expenses | 3.81M | 3.33M | 2.84M | 3.62M | 5.19M | 7.02M | 11.92M | 18.18M | 16.88M | 17.15M |
| OpEx % of Revenue | 4.99% | 5.32% | 4.12% | 3.38% | 3.13% | 1.72% | 2.88% | 5.89% | 5.23% | 5.21% |
| Selling, General & Admin | 2.82M | 1.66M | 1.34M | 1.68M | 2.34M | 2.87M | 6.04M | 9.06M | 8.6M | 10.05M |
| SG&A % of Revenue | 3.7% | 2.66% | 1.95% | 1.57% | 1.41% | 0.7% | 1.46% | 2.94% | 2.66% | 3.05% |
| Research & Development | 980.87K | 1.66M | 1.5M | 1.94M | 2.85M | 4.08M | 5.88M | 9.12M | 8.27M | 7.1M |
| R&D % of Revenue | 1.29% | 2.66% | 2.17% | 1.81% | 1.72% | 1% | 1.42% | 2.96% | 2.56% | 2.16% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 70.59K | 0 | 0 | 0 | 0 |
| Operating Income | -3.53M | -3.1M | -2.66M | -3.17M | -4.61M | -4.36M | -9.72M | -16.74M | -15.58M | -15.7M |
| Operating Margin % | -4.63% | -4.96% | -3.87% | -2.96% | -2.78% | -1.07% | -2.35% | -5.43% | -4.82% | -4.77% |
| Operating Income Growth % | 0.14% | 0.12% | 0.14% | -0.19% | -0.45% | 0.05% | -1.23% | -0.72% | 0.07% | -0.01% |
| EBITDA | -3.47M | -3.05M | -2.63M | -3.14M | -4.45M | -4.3M | -9.6M | -16.49M | -15.25M | -15.36M |
| EBITDA Margin % | -4.54% | -4.88% | -3.82% | -2.93% | -2.69% | -1.05% | -2.32% | -5.35% | -4.72% | -4.67% |
| EBITDA Growth % | 0.13% | 0.12% | 0.14% | -0.19% | -0.42% | 0.03% | -1.23% | -0.72% | 0.08% | -0.01% |
| D&A (Non-Cash Add-back) | 63.02K | 54.07K | 33.38K | 30.8K | 155.37K | 63K | 127K | 248K | 323K | 332K |
| EBIT | -3.75M | -3.27M | -2.82M | -3.47M | -4.75M | -4.14M | -9.72M | -16.74M | -15.58M | -15.7M |
| Net Interest Income | -189.82K | -151.04K | -59.22K | -72.59K | -201.57K | 412K | -171K | -239K | 924K | 378K |
| Interest Income | 8.71K | 3.9K | 1.95K | 556 | -178.76K | 4.04K | 0 | 0 | 924K | 378K |
| Interest Expense | 198.53K | 154.94K | 61.16K | 73.15K | 22.81K | 31.72K | 171K | 239K | 0 | 0 |
| Other Income/Expense | -222.87K | -166.64K | -210.9K | -363.76K | -165.18K | 412K | -171K | -239K | 924K | 378K |
| Pretax Income | -3.75M | -3.27M | -2.88M | -3.53M | -4.77M | -4.69M | -9.89M | -16.98M | -14.65M | -15.32M |
| Pretax Margin % | -4.92% | -5.23% | -4.17% | -3.3% | -2.88% | -1.15% | -2.39% | -5.5% | -4.54% | -4.65% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 86.77K | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1.02% | 1.02% | 1.01% | 1% | 1% |
| Net Income | -3.75M | -3.27M | -2.88M | -3.53M | -4.76M | -4.78M | -10.07M | -17.22M | -14.65M | -15.32M |
| Net Margin % | -4.92% | -5.23% | -4.17% | -3.3% | -2.87% | -1.17% | -2.43% | -5.58% | -4.54% | -4.65% |
| Net Income Growth % | 0.2% | 0.13% | 0.12% | -0.23% | -0.35% | -0% | -1.11% | -0.71% | 0.15% | -0.05% |
| Net Income (Continuing) | -3.75M | -3.27M | -2.88M | -3.53M | -4.77M | -3.73M | -9.89M | -16.98M | -14.65M | -15.32M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.15 | -0.62 | -0.46 | -0.30 | -0.35 | -0.28 | -0.35 | -0.47 | -0.32 | -0.30 |
| EPS Growth % | 0.69% | 0.46% | 0.26% | 0.35% | -0.17% | 0.2% | -0.25% | -0.34% | 0.32% | 0.06% |
| EPS (Basic) | -0.82 | -0.62 | -0.46 | -0.30 | -0.35 | -0.28 | -0.35 | -0.47 | -0.32 | -0.30 |
| Diluted Shares Outstanding | 4.6M | 5.3M | 6.26M | 11.67M | 13.62M | 17.13M | 28.55M | 37.02M | 45.64M | 50.88M |
| Basic Shares Outstanding | 4.6M | 5.3M | 6.26M | 11.67M | 13.62M | 17.13M | 28.55M | 37.02M | 45.64M | 50.88M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 4.92M | 3.23M | 1.86M | 5.15M | 6.9M | 9.68M | 30.32M | 28.13M | 14.18M | 10.75M |
| Cash & Short-Term Investments | 4.52M | 2.82M | 1.46M | 4.19M | 5.78M | 3.5M | 25.62M | 23.66M | 11.06M | 7.56M |
| Cash Only | 4.52M | 2.82M | 1.46M | 4.19M | 5.78M | 3.5M | 25.62M | 23.66M | 10.53M | 7.56M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 529K | 0 |
| Accounts Receivable | 2 | 65.77K | 2 | 250.38K | 2 | 165K | 771K | 366K | 103K | 221K |
| Days Sales Outstanding | 0 | 38.38 | 0 | 85.26 | 0 | 14.74 | 68.01 | 43.3 | 11.64 | 24.51 |
| Inventory | 322.26K | 319.5K | 300.38K | 653.18K | 717.34K | 1.14M | 1.96M | 2.86M | 2.27M | 1.99M |
| Days Inventory Outstanding | 241.92 | 288.66 | 213.12 | 382.57 | 242.16 | 292.33 | 367.25 | 635.86 | 430.47 | 394.36 |
| Other Current Assets | 64.3K | 0 | 62.44K | 1 | 104.54K | 266K | 0 | 296K | 11K | 188K |
| Total Non-Current Assets | 127.83K | 86.83K | 74.81K | 101.43K | 417.58K | 658.36K | 1.96M | 2.06M | 2.23M | 1.82M |
| Property, Plant & Equipment | 91.71K | 61.87K | 43.73K | 73.81K | 377.44K | 621.67K | 1.63M | 2.02M | 2.19M | 1.78M |
| Fixed Asset Turnover | 8.32x | 10.11x | 15.76x | 14.52x | 4.39x | 6.57x | 2.54x | 1.52x | 1.47x | 1.85x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 20.27K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 36.12K | 24.96K | 31.07K | 27.61K | 19.88K | 36.7K | 333K | 34K | 34K | 46K |
| Total Assets | 5.05M | 3.31M | 1.93M | 5.25M | 7.32M | 10.34M | 32.28M | 30.19M | 16.41M | 12.58M |
| Asset Turnover | 0.15x | 0.19x | 0.36x | 0.20x | 0.23x | 0.40x | 0.13x | 0.10x | 0.20x | 0.26x |
| Asset Growth % | 0.53% | -0.34% | -0.42% | 1.72% | 0.39% | 0.41% | 2.12% | -0.06% | -0.46% | -0.23% |
| Total Current Liabilities | 649.65K | 557.12K | 1.57M | 1.17M | 3.63M | 3.91M | 4.02M | 4.34M | 3.87M | 5.51M |
| Accounts Payable | 88.12K | 124.78K | 152.49K | 452.98K | 425.67K | 645K | 881K | 714K | 502K | 1.23M |
| Days Payables Outstanding | 66.15 | 112.74 | 108.19 | 265.31 | 143.7 | 165.07 | 165.5 | 158.91 | 94.99 | 244.39 |
| Short-Term Debt | 0 | 0 | 936.24K | 0 | 0 | 0 | 0 | 0 | 0 | 298K |
| Deferred Revenue (Current) | 0 | 0 | -1000K | 0 | 1000K | 0 | 884K | 646K | 187K | 334K |
| Other Current Liabilities | 359.15K | 297.93K | 292.9K | 520.15K | 2.66M | 3.05M | 472K | 601K | 677K | 468K |
| Current Ratio | 7.58x | 5.79x | 1.18x | 4.42x | 1.90x | 2.48x | 7.54x | 6.49x | 3.66x | 1.95x |
| Quick Ratio | 7.08x | 5.22x | 0.99x | 3.86x | 1.70x | 2.18x | 7.06x | 5.83x | 3.08x | 1.59x |
| Cash Conversion Cycle | 175.77 | 214.3 | 104.93 | 202.52 | 98.46 | 142.01 | 269.76 | 520.25 | 347.13 | 174.48 |
| Total Non-Current Liabilities | 552.3K | 652.78K | 621.19K | 720.62K | 1.06M | 1.85M | 1.3M | 430K | 376K | 161K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 110.6K | 118K | 685K | 430K | 376K | 161K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | -1.76M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 346.83K | 815.9K | 618K | 0 | 0 | 0 |
| Total Liabilities | 1.2M | 1.21M | 2.19M | 1.89M | 4.69M | 5.75M | 5.32M | 4.77M | 4.25M | 5.67M |
| Total Debt | 0 | 0 | 936.24K | 0 | 245.18K | 301.04K | 909K | 597K | 599K | 459K |
| Net Debt | -4.52M | -2.82M | -521.06K | -4.19M | -5.53M | -3.2M | -24.71M | -23.06M | -9.93M | -7.11M |
| Debt / Equity | - | - | - | - | 0.09x | 0.07x | 0.03x | 0.02x | 0.05x | 0.07x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -17.78x | -20.03x | -43.57x | -43.34x | -202.02x | -137.50x | -56.87x | -70.04x | - | - |
| Total Equity | 3.85M | 2.1M | -256.93K | 3.37M | 2.63M | 4.58M | 26.96M | 25.42M | 12.16M | 6.9M |
| Equity Growth % | 1.09% | -0.45% | -1.12% | 14.1% | -0.22% | 0.75% | 4.88% | -0.06% | -0.52% | -0.43% |
| Book Value per Share | 0.84 | 0.40 | -0.04 | 0.29 | 0.19 | 0.27 | 0.94 | 0.69 | 0.27 | 0.14 |
| Total Shareholders' Equity | 3.85M | 2.1M | -256.93K | 3.37M | 2.63M | 4.58M | 26.96M | 25.42M | 12.16M | 6.9M |
| Common Stock | 680.13K | 1.13M | 1.26M | 2.7M | 3.47M | 5.03M | 0 | 0 | 0 | 0 |
| Retained Earnings | -29.63M | -33.34M | -39.78M | -40.24M | -48.54M | -56.97M | -58.43M | -75.41M | -90.06M | -105.38M |
| Treasury Stock | -44.57K | -45.23K | -50.06K | -46.2K | -50.25K | -41K | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 2.3M | 2.68M | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -3.35M | -3.13M | -2.62M | -3.06M | -1.74M | -3.69M | -12.61M | -14.29M | -12.52M | -12.56M |
| Operating CF Margin % | -4.39% | -5.01% | -3.81% | -2.86% | -1.05% | -0.9% | -3.05% | -4.63% | -3.88% | -3.82% |
| Operating CF Growth % | 0.01% | 0.07% | 0.16% | -0.17% | 0.43% | -1.12% | -2.42% | -0.13% | 0.12% | -0% |
| Net Income | -3.75M | -3.27M | -2.88M | -3.53M | -4.77M | -3.73M | -9.89M | -16.98M | -14.65M | -15.32M |
| Depreciation & Amortization | 63.02K | 54.07K | 33.38K | 30.8K | 155.37K | 63K | 127K | 248K | 323K | 332K |
| Stock-Based Compensation | 364.02K | 14.82K | 115.38K | 209.76K | 363.58K | 229K | 316K | 1.86M | 1.31M | 869K |
| Deferred Taxes | 73.78K | 17.16K | 76.82K | 7.43K | 2.6K | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -64.56K | 139.6K | 4.89K | 212.68K | -59.49K | -452K | 5K | 359K | -25K | 39K |
| Working Capital Changes | -34.58K | -86.83K | 20.43K | 9.56K | 2.57M | 200K | -3.16M | 214K | 523K | 1.51M |
| Change in Receivables | 0 | 0 | 0 | 0 | 98.15K | 44K | -362K | 378K | 471K | -118K |
| Change in Inventory | -31.25K | 7.54K | 53.23K | -375.98K | -6.93K | -386K | -891K | -902K | 582K | 287K |
| Change in Payables | 0 | 0 | 0 | 0 | 2.29M | 217K | 236K | -167K | -212K | 730K |
| Cash from Investing | -6.15K | -22.88K | -8.63K | -64.26K | -102.23K | -4.67M | 3.79M | -891K | -713K | 446K |
| Capital Expenditures | -6.15K | -22.88K | -8.63K | -64.26K | -102.23K | -223K | -533K | -891K | -480K | -71K |
| CapEx % of Revenue | 0.01% | 0.04% | 0.01% | 0.06% | 0.06% | 0.05% | 0.13% | 0.29% | 0.15% | 0.02% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 4.33M | 0 | -233K | -12K |
| Cash from Financing | 5.35M | 1.4M | 1.05M | 5.98M | 3.06M | 5.86M | 30.89M | 13.58M | 83K | 9.19M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - | - |
| Other Financing | -51.23K | -47.31K | 26.18K | -2.66K | -205.9K | 171.98K | 337K | 2K | 0 | 0 |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -3.36M | -3.15M | -2.63M | -3.13M | -1.84M | -3.91M | -13.14M | -15.18M | -13M | -12.63M |
| FCF Margin % | -4.4% | -5.04% | -3.82% | -2.92% | -1.11% | -0.96% | -3.17% | -4.92% | -4.03% | -3.84% |
| FCF Growth % | 0.02% | 0.06% | 0.17% | -0.19% | 0.41% | -1.12% | -2.36% | -0.16% | 0.14% | 0.03% |
| FCF per Share | -0.73 | -0.60 | -0.42 | -0.27 | -0.14 | -0.23 | -0.46 | -0.41 | -0.28 | -0.25 |
| FCF Conversion (FCF/Net Income) | 0.89x | 0.96x | 0.91x | 0.87x | 0.37x | 0.77x | 1.25x | 0.83x | 0.85x | 0.82x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -131.83% | -109.86% | -311.57% | -227.28% | -158.86% | -132.53% | -63.83% | -65.74% | -77.97% | -160.7% |
| Return on Invested Capital (ROIC) | - | - | - | - | - | -236.64% | -402% | -545.13% | -509.13% | -1162.67% |
| Gross Margin | 36.27% | 35.41% | 25.38% | 41.86% | 34.77% | 65.08% | 53.04% | 46.84% | 40.26% | 44.09% |
| Net Margin | -491.81% | -522.82% | -417.15% | -329.7% | -287.18% | -116.96% | -243.26% | -558.09% | -453.76% | -465.45% |
| Debt / Equity | - | - | - | - | 0.09x | 0.07x | 0.03x | 0.02x | 0.05x | 0.07x |
| Interest Coverage | -17.78x | -20.03x | -43.57x | -43.34x | -202.02x | -137.50x | -56.87x | -70.04x | - | - |
| FCF Conversion | 0.89x | 0.96x | 0.91x | 0.87x | 0.37x | 0.77x | 1.25x | 0.83x | 0.85x | 0.82x |
| Revenue Growth | -28.61% | -18.01% | 10.21% | 55.49% | 54.64% | 146.41% | 1.31% | -25.45% | 4.67% | 1.92% |
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Other Countries Member | 1.29M | 1.51M | 1.46M |
| Other Countries Member Growth | - | 17.27% | -3.83% |
| UNITED STATES | 604K | 751K | 870K |
| UNITED STATES Growth | - | 24.34% | 15.85% |
| JAPAN | 1.13M | 480K | 481K |
| JAPAN Growth | - | -57.52% | 0.21% |
| INDIA | - | - | 413K |
| INDIA Growth | - | - | - |
| CHINA | - | 440K | 41K |
| CHINA Growth | - | - | -90.68% |
| ISRAEL | 30K | 30K | 30K |
| ISRAEL Growth | - | 0.00% | 0.00% |
| THAILAND | 30K | 14K | - |
| THAILAND Growth | - | -53.33% | - |
IceCure Medical Ltd (ICCM) reported $3.0M in revenue for fiscal year 2024. This represents a 178% increase from $1.1M in 2014.
IceCure Medical Ltd (ICCM) grew revenue by 1.9% over the past year. Growth has been modest.
IceCure Medical Ltd (ICCM) reported a net loss of $15.3M for fiscal year 2024.
IceCure Medical Ltd (ICCM) has a return on equity (ROE) of -160.7%. Negative ROE indicates the company is unprofitable.
IceCure Medical Ltd (ICCM) had negative free cash flow of $13.8M in fiscal year 2024, likely due to heavy capital investments.